Get the Stockscreener App
23.65
0.02%
-0.005
After Hours:
23.65
Lifemd Inc stock is traded at $23.65, with a volume of 642.
It is down -0.02% in the last 24 hours and down -1.46% over the past month.
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
See More
Previous Close:
$23.66
Open:
$23.7499
24h Volume:
642
Relative Volume:
0.28
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-1.13%
1M Performance:
-1.46%
6M Performance:
-1.42%
1Y Performance:
-4.64%
1-Day Range:
$23.61
$23.75
1-Week Range:
$23.61
$24.10
52-Week Range:
$18.50
$24.78
Lifemd Inc Stock (LFMDP) Company Profile
Name
Lifemd Inc
Sector
Industry
Phone
866 351 5907
Address
236 Fifth Avenue, Suite 400, New York
Compare LFMDP vs HITI, PETS, POM, SCNX, HKPD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LFMDP
Lifemd Inc
|
23.65 | 0 | 0 | 0 | 0 | 0.00 |
HITI
High Tide Inc
|
2.45 | 214.47M | 452.61M | -35.30M | 13.25M | -0.3863 |
PETS
Petmed Express Inc
|
2.30 | 47.94M | 182.67M | -64.87M | -22.92M | -3.1193 |
POM
Pomdoctor Ltd Adr
|
0.3801 | 45.29M | 0 | 0 | 0 | 0.00 |
SCNX
Scienture Holdings Inc
|
0.4012 | 15.89M | 653.40K | -20.19M | -11.11M | -1.8091 |
HKPD
Cellyan Biotechnology Co Ltd
|
0.685 | 14.69M | 0 | 0 | 0 | 0.00 |
Lifemd Inc Stock (LFMDP) Latest News
Earnings Preview: LifeMD to Report Financial Results Post-market on May 06 - Moomoo
[DEF 14A] LifeMD, Inc. Definitive Proxy Statement - Stock Titan
LifeMD (LFMD) soars 23.7%: Is further upside left in the stock? - MSN
LifeMD (LFMD) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
LifeMD to Report First Quarter 2026 Financial Results on May 6 - The Manila Times
After the bell May 6: LifeMD sets Q1 results call for 4:30 p.m. ET - Stock Titan
LifeMD, Inc. (LFMD) Reports Q2 Loss, Lags Revenue Estimates - MSN
LFMD (LifeMD Inc.) shares rise nearly four percent after Q4 2025 earnings narrowly miss analyst consensus estimates. - Cổng thông tin điện tử Tỉnh Sơn La
LifeMD (LFMD) Stock: Complete Guide (+3.53%) 2026-04-22Safe Entry Stocks - UBND thành phố Hải Phòng
Analysts Expect Breakeven For LifeMD, Inc. (NASDAQ:LFMD) Before Long - Moomoo
LifeMD (LFMD) Soars 23.7%: Is Further Upside Left in the Stock? - Yahoo Finance
LifeMD (LFMD) Stock: Resistance Rejection Signals (Momentum Building) 2026-04-20Crowd Sentiment Stocks - Cổng thông tin điện tử Tỉnh Sơn La
Is LifeMD (LFMD) stock testing breakout levels (Overhead Buying) 2026-04-18Continuation Signals - Xã Vĩnh Công
How The LifeMD (LFMD) Story Is Shifting Around GLP-1 Growth Plans And 2026 Expectations - Yahoo Finance
JPMorgan Chase & Co. Has $414,000 Stock Holdings in LifeMD, Inc. $LFMD - MarketBeat
Hims & Hers Powers Patient-Provider Connectivity via Digital Platforms - TradingView
LifeMD, Inc. (NASDAQ:LFMD) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Breakout Zone: Is LifeMD Inc gaining market share2026 Catalysts & Real-Time Volume Trigger Notifications - baoquankhu1.vn
LifeMD adds Eli Lilly’s oral weight loss drug to platform By Investing.com - Investing.com Canada
LifeMD adds Eli Lilly’s oral weight loss drug to platform - Investing.com
LifeMD® Now Offering Eli Lilly and Company’s Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management - ChartMill
Dividend Watch: How sensitive is LifeMD Inc to inflation2026 Price Targets & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
LifeMD (NASDAQ:LFMD) Trading Down 4.2%What's Next? - MarketBeat
Big Money Moves: Why is LifeMD Inc stock going up2026 Market Outlook & Fast Moving Stock Trade Plans - baoquankhu1.vn
LFMD Technical Analysis & Stock Price Forecast - intellectia.ai
LifeMD, Inc. (LFMD) Stock Analysis: Exploring A Potential 181.34% Upside In Telehealth - DirectorsTalk Interviews
LifeMD Earnings Call Highlights Aggressive Growth Push - TipRanks
LifeMD, Inc. (LFMDP) Stock Price, News, Quote & History - Yahoo! Finance Canada
LFMDP SEC FilingsLifemd, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
200,000 LifeMD (LFMD) RSUs awarded to marketing head - Stock Titan
[Form 3] LifeMD, Inc. Initial Statement of Beneficial Ownership - Stock Titan
LifeMD (LFMD) CFO Atul Kavthekar listed as reporting person in Form 3 - Stock Titan
Mizuho Upgrades LifeMD (LFMD) with Raised Price Target to $8.00 - GuruFocus
LifeMD launches Wegovy subscription program with Novo Nordisk By Investing.com - Investing.com South Africa
LifeMD Offers Novo Nordisk's Industry-First Wegovy Telehealth Subscription Program - Bitget
Slash Your Wegovy Costs: Novo Nordisk Reveals First-Ever Subscription Plan - Benzinga
NVO: Novo Nordisk's Wegovy Subscription Program Launches with Li - GuruFocus
LifeMD launches Wegovy subscription program with Novo Nordisk - Investing.com
LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program - marketscreener.com
Novo to sell Wegovy subscriptions on Hims, LifeMD, and others - seekingalpha.com
Up to $1,200 off Wegovy: LifeMD launches Novo telehealth plan - Stock Titan
Earnings Miss: Why is LifeMD Inc stock going up2026 Risk Factors & Breakout Confirmation Trade Signals - baoquankhu1.vn
LifeMD’s GLP-1 Growth Looks Real, But The Stock’s Still Cheap - Finimize
LifeMD Offers Novo Nordisk’s Ozempic For $499 A Month To Eligible Patients - MSN
LifeMD: Comparing The High Yield Preferred Stock To An Options Income Strategy (LFMD) - Seeking Alpha
LifeMD, Inc. 8.875% CUM PFD A declares $0.5547 dividend - MSN
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock - Sahm
How Lifemd Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP) Affects Rotational Strategy Timing - Stock Traders Daily
Lifemd Inc Stock (LFMDP) Financials Data
There is no financial data for Lifemd Inc (LFMDP). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.72%
1.45%
Cap:
|
Volume (24h):